LATEST

CAN.HEAL Press Release: Europe Unites to Deliver Precision Cancer

Press Release: BRECISE Holds First Face-to-Face Kick-Off Meeting in Madrid

March 20-21, 2025

BEACON: Final Event

Milan, Italy, October 22-23, 2024

World Cancer Congress 2024: EAPM Side Event

ESMO 2024 – Side Event, September 14, 2025

The right prevention and treatment for the right patient at the right time

Our vision is grounded in the profound belief that healthcare should be as unique as the individuals it serves. In a world that’s increasingly interconnected and diverse, EAPM is dedicated to spearheading a new era in healthcare — one where precision and personalization redefine the standards of prevention and treatment strategies. Join us in exploring the forefront of medical innovation, where our commitment to individualized care is not just a goal but a revolution. Welcome to a future where healthcare truly fits you.

Map

This interactive map visualises the current state of genomic data integration and molecular diagnostics implementation across selected European countries. It reflects findings from EAPM’s national factsheets, assessing the readiness and challenges in adopting Next-Generation Sequencing (NGS) and health data governance to support personalised cancer care.

Countries are highlighted based on their overall level of maturity in:

  • Health data infrastructure and sharing
  • NGS implementation in clinical practice
  • Governance frameworks
  • Workforce capacity and education
  • Reimbursement and access

This classification provides a snapshot of progress and key barriers, supporting policymakers, clinicians, and stakeholders in identifying priority areas for action and collaboration.

Legend:

🟢 Advanced Integration
Countries with mature data infrastructure, routine NGS use, established governance, and existing reimbursement mechanisms.

🟡 Developing Capacity
Countries with established infrastructure and some NGS application but facing challenges in reimbursement, workforce capacity, or standardisation.

🟠 Emerging Efforts
Countries building infrastructure and initial data integration, but with significant needs in governance, workforce, and diagnostics access.

NEWS

Latest updates

Be informed and stay informed on all
news, events and publication updated.

CAN.HEAL Press Release: Europe Unites to Deliver Precision Cancer

Press Release: BRECISE Holds First Face-to-Face Kick-Off Meeting in Madrid

Academic Article published at the American Association for Cancer Research Congress in San Diego

Academic article published in the Current Oncology journal

INTRODUCTION

About EAPM

Find out everything about project, who we are and what we do

The European Alliance for Personalised Medicine was launched in March 2012, with the aim of improving patient care by accelerating the development, delivery and uptake of personalised medicine and earlier diagnostics, through consensus

The multi-stakeholder nature of the Alliance allows it to act as a one- shop for stakeholders in personalised medicine and personalised healthcare.

EVENTS

Let's get together

Be informed and stay informed on all
news, events and publication updated.

BEACON: Final Event

Milan, Italy, October 22-23, 2024

World Cancer Congress 2024: EAPM Side Event

Name: High-level Conference – Fighting Cancer around the World: A Framework for Action Location: Institute of Global Health; University of Geneva, Campus Biotech – G6; Chemin des Mines 9, 1202

ESMO 2024 – Side Event, September 14, 2025

Name: Forward Together with Innovation: The Why, What, and How of Tackling the Implementation Gap for Healthcare in Different Regions Location: Room Las Arenas IV, Hotel Porta Fira, Pl. d’Europa,

ESMO 2024 – Side Event, September 13, 2024

Name: The missing element in bringing real innovation to Europe’s healthcare system and tangible benefits for cancer patients Location: Hotel Porta Fira, Pl. d’Europa, 45, 08908 L’Hospitalet de Llobregat, Barcelona,

EVENTS

Become a partner

Be informed and stay informed on all
news, events and publication updated.